Physician profile
Marcella Antoniewicz
NPI 1538551197
$5,905.97
in general payments reported to CMS, 2019-2025
20 companies · $1,580 in 2025
The $1,580 reported for 2025 was more than what 91% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,262 · 2022: $774 · 2023: $1,335 · 2024: $955 · 2025: $1,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,870.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,242.98 | 2021-2025 | |
| Aop Health US, LLC | $326.40 | 2025 | Rapiblyk |
| Alnylam Pharmaceuticals INC. | $304.78 | 2022-2025 | Amvuttra, Onpattro |
| Novartis Pharmaceuticals Corporation | $302.40 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $292.62 | 2021-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $278.69 | 2021-2024 | Lifevest |
| Abbott Laboratories | $210.98 | 2021-2025 | Navitor, Cardiomems |
| Pfizer INC. | $197.09 | 2021-2024 | |
| Amgen INC. | $137.58 | 2021-2023 | Repatha |
| Recor Medical INC | $124.06 | 2025 | Paradise Ultrasound Renal Denervation System |
| E.R. Squibb & Sons, L.L.C. | $110.97 | 2022-2023 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $108.92 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $92.63 | 2021-2022 | |
| Esperion Therapeutics, INC. | $66.00 | 2021 | |
| Abiomed | $29.19 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $21.09 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.31 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $15.58 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $13.73 | 2023 | |
| B. Braun Interventional Systems INC. | $12.97 | 2023 | No Marketed Product Name |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcella Antoniewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.